Adrenaline auto-injectors

Adrenaline auto-injectors

Towards the end of 2018, there was a limited supply of adrenaline auto injectors and we have collated the following information to be easily accessible and helpful in managing the current supply constraints.

The three products and their current supply arrangements are:

Emerade 150mcg, 300mcg and 500mcg available from AAH and Phoenix

Epipen 150mcg and 300mcg available from Alliance Healthcare

Jext 150mcg and 300mcg available from Alliance Healthcare


LATEST UPDATE: Supply Disruption Alert: Emerade 500 microgram and 300 microgram adrenaline auto-injector devices

Supply Status Update: EpiPen® 0.3mg and 0.15mg Adrenaline Auto-Injectors

Adrenaline 150 microgram auto-injector validation process no longer required

Update to urgent action required by pharmacy teams – revised interim protocol

Urgent action required by pharmacy teams

Adrenaline 150mcg validation protocol 

Q&A for pharmacies

Extended expiry dates for Epipen 300mcg, Jext 150mcg and 300mcg

Epipen Junior shortage – patient letter – including guidelines to prescribe 300mcg dose for patients above 25kg (4 stone) 

Epipen 150mcg and 300mcg supply issue update September 2018 

Epipen 300mcg supply issues



Supply Disruption Alert (SDA/2019/004) 1st August 2019

CAS DHSC Supply Disruption Alert 15.10.2018

CAS DHSC Supply Disruption Alert 28.09.2018


Useful resources for community pharmacies

Adrenaline for anaphylaxis kits 

Anaphylaxis Campaign website

How to use Emerade

How to use Epipen

How to use Jext 

Summary of the key differences between the three presentations of adrenaline auto-injectors.


Latest Dispensing and Supply news

View more Dispensing and Supply news >